Carmell Corporation - Common Stock Share · US1429221039 · CTCX (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Carmell Corporation - Common Stock

No Price

01.05.2026 13:59

Current Prices from Carmell Corporation - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
UTC	XAGE	USD	01.05.2026 13:59	0,33 USD	0,02 USD +6,27 %
NASDAQ	XAGE	USD	28.04.2026 14:21	0,31 USD	-

Share Float & Liquidity

Free Float 48,94 %

Shares Float 14,74 M

Shares Outstanding 30,12 M

Company Profile for Carmell Corporation - Common Stock Share

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.